New Enhancing CLIA Act: What Lab Directors Need to Know
The proposal seeks to move any future LDT authority away from the FDA
Already a member? Log in here
Essential
Subscribe today for access to
Articles and Reports
How to Stay Ahead of Anticipated CLIA Deficiencies
Consultant Nora Hess offers suggestions for clinical labs to navigate these problems
Already a member? Log in here
FDA Watch: Natera, Valar Labs Receive FDA Clearances for Bladder Cancer Tests
Natera’s assay focuses on the need for adjuvant therapy, while Valar’s test stratifies risk of recurrence
Already a member? Log in here
News-At-A-Glance: Estimation of HbA1c for Diabetic Patients
...
Already a member? Log in here
News-At-A-Glance: Tuomey Given Go-Ahead to File Bankruptcy
...
Already a member? Log in here
News-At-A-Glance: Illinois Could Prohibit Markup of AP Services
...
Already a member? Log in here
Compliance Corner
...
Already a member? Log in here
OIG Again Demonstrates Its Prowess in Bringing Fraudsters to Justice
...
Already a member? Log in here
Two New Proposed Rules Would Expand OIG Exclusion and CMP Authority
...
Already a member? Log in here
ABN Deemed Invalid by QIC Because It Used an Abbreviation
...
Already a member? Log in here
CMS Data Dump Reveals Pain for Alabama Clinic
...
Already a member? Log in here
Improper Medicare Advantage Plan Noncoverage Notices May Benefit Labs
...
Already a member? Log in here